| abstract |
The present invention provides to a compound having melanin-concentrating hormone receptor antagonistic action and low toxicity, and useful as a agent for the prophylaxis or treatment of obesity and the like. n The present invention relates to a compound represented by the formula (I): n n n n n n n n n n wherein each symbol is as defined in the specification, or a salt thereof. |